Pfizer Inc
NYSE: PFE
$28.84
-$0.09 (-0.3%)
Closing Price on October 22, 2024
PFE Articles
Wikimedia CommonsSome companies reportedly have decided to delay their earnings reports as Hurricane Sandy heads for the East Coast and the major U.S. markets are close today, and possibly Tuesday....
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) said today that it will acquire privately held NextWave Pharmaceuticals. NextWave is a specialty pharmaceutical company that focuses on the development and commercialization...
Published:
The coming fiscal cliff represents a huge hurdle for America. Government and private sector forecasters have warned that the expiration of tax cuts, along with hundreds of billions of dollars in...
Published:
Last Updated:
The three major U.S. stock indexes opened lower this morning following a weaker-than-expected report on U.S. personal income and inline personal consumption spending (more coverage here). U.S....
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday. ADTRAN Inc. (NASDAQ: ADTN) cut to Underperform at BofA/ML. AGCO Corp....
Published:
Last Updated:
The fiscal cliff has been described as a potential disaster for the finances of individuals and corporations alike. If Congress and the White House do not reach an agreement on the budget and tax...
Published:
While many individual Americans are struggling financially, some of the largest corporations in the United States are sitting on billions in cash. Moody’s pointed out in March that U.S....
Published:
Last Updated:
More American companies are among the 20 largest in the world than at any time in the past decade. This is because earnings at U.S. companies have risen faster than the rest of the world as the...
Published:
While most of the 30 stocks on the Dow Jones Industrial closed in the red yesterday, Kraft Foods Inc. (NASDAQ: KFT) and Pfizer (NYSE: PFE) bucked that trend. Kraft climbed 0.71%, according to...
Published:
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in...
Published:
Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider. Elan could be getting closer and closer...
Published:
Last Updated:
Drug maker Pfizer Inc. (NYSE: PFE) has filed a Form S-1 with the SEC for an initial public offering of the company’s animal health unit into a company to be called Zoetis Inc. Pfizer expects to...
Published:
Drug maker Pfizer Inc. (NYSE: PFE) today announced that it has reached settlements with the US Justice Department and the Securities and Exchange Commission related to improper payments (aka, bribes)...
Published:
Chesapeake Energy Corp. (NYSE: CHK) sells assets to improve earnings. (Reuters) Standard Chartered may lose its New York banking license over allegations it hid $250 billion in transactions tied to...
Published:
Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed...
Published:
Last Updated: